In palmitic-acid-treated macrophages, the amount of pSTAT3 decreased after treatment with liraglutide, suggesting that STAT3-mediated proinflammatory signaling in macrophages is critical in nonalcoholic steatohepatitis livers [34]. This evidence concerns the gene STAT3 and metabolic dysfunction-associated steatohepatitis.